Exposome-guided precision neurorehabilitation: A scoping review of biology, circuits, exposure, and recovery

Neurorehabilitation is an exposure-rich intervention in which treatment dose, behavioral practice, neuromodulation, and environmental conditions act on biologically heterogeneous patients. We conducted a scoping review of same-study evidence linking genetic, epigenetic, or molecular factors with rehabilitation, lifestyle, or exposome-related exposures and recovery outcomes. Searches identified 21 eligible studies, predominantly in stroke, with smaller multiple sclerosis and traumatic brain injury clusters. Candidate-gene analyses, especially brain-derived neurotrophic factor (BDNF) Val66Met, dominated a heterogeneous literature with domain-specific, mixed, or null findings. Current evidence does not support routine genotype-based treatment selection. We propose a four-level research architecture linking biological state, measurable exposures, circuit engagement, and recovery phenotypes. This framework is not a validated clinical decision tool. Its nearer-term purpose is to guide exposure measurement and mechanistic trial design, with prospective interaction testing and external validation required before clinical use.

Authors

Institutions

Publication Details

Journal
iScience
Published
2026-11-18
DOI
https://doi.org/10.1016/j.isci.2026.118284
Primary Topic
Stroke Rehabilitation and Recovery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exposome-guided precision neurorehabilitation: A scoping review of biology, circuits, exposure, and recovery

Elena Rossato, Andrea Calderone, Rocco Salvatore Calabrò, Angelo Quartarone et al.
iScience
Stroke Rehabilitation and Recovery
article

Exposome-guided precision neurorehabilitation: A scoping review of biology, circuits, exposure, and recovery

Elena Rossato, Andrea Calderone, Rocco Salvatore Calabrò, Angelo Quartarone, Franco Molteni
article en

Abstract

Neurorehabilitation is an exposure-rich intervention in which treatment dose, behavioral practice, neuromodulation, and environmental conditions act on biologically heterogeneous patients. We conducted a scoping review of same-study evidence linking genetic, epigenetic, or molecular factors with rehabilitation, lifestyle, or exposome-related exposures and recovery outcomes. Searches identified 21 eligible studies, predominantly in stroke, with smaller multiple sclerosis and traumatic brain injury clusters. Candidate-gene analyses, especially brain-derived neurotrophic factor (BDNF) Val66Met, dominated a heterogeneous literature with domain-specific, mixed, or null findings. Current evidence does not support routine genotype-based treatment selection. We propose a four-level research architecture linking biological state, measurable exposures, circuit engagement, and recovery phenotypes. This framework is not a validated clinical decision tool. Its nearer-term purpose is to guide exposure measurement and mechanistic trial design, with prospective interaction testing and external validation required before clinical use.

iScienceVol. 29(12)
Ospedale Sacro Cuore Don Calabria (IT), Ospedale Valduce (IT), Centro Neurolesi Bonino Pulejo (IT)
Ministero della Salute
Good health and well-being
Stroke Rehabilitation and Recovery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon